Volumen | 37 |
|
|||||
News | - | ||||||
Tageshoch | 190,00 | Niedrig Hoch |
|||||
Tagestief | 189,05 |
Name | Symbol | Markt | Aktientyp |
---|---|---|---|
Biogen Inc | 1BIIB | Italien | Ordinary Share |
Handelsbeginn | Niedrig | Hoch | Schlusskurs | Handelsende |
---|---|---|---|---|
189,15 | 189,05 | 190,00 | 189,10 | 189,15 |
Trades | Volumen | Durchsch. Volumen | 52 Week Range |
---|---|---|---|
5 | 37 | - | 177,65 - 244,60 |
Letzte Trade | Typ | Menge | Kurs | Währung |
---|---|---|---|---|
15:28:34 | 20 | 189,10 € | EUR |
News Biogen
Datum | Zeit | Quelle | Überschrift |
---|---|---|---|
25.4.2024 | 22:05 | GlobeNewswire Inc. | Biogen Receives Positive CHMP Opinion for TOFIDENCE™.. |
06.3.2024 | 13:30 | GlobeNewswire Inc. | New Biomarker Data Add Further Evidence Supporting the.. |
04.3.2024 | 22:15 | GlobeNewswire Inc. | Biogen Highlights New Data at the International Conference.. |
23.2.2024 | 13:00 | GlobeNewswire Inc. | Biogen’s QALSODY® (tofersen), the First Therapy to Treat.. |
12.2.2024 | 22:06 | GlobeNewswire Inc. | Biogen Received European Commission Approval for SKYCLARYS®.. |
31.1.2024 | 13:30 | GlobeNewswire Inc. | Biogen to Realign Resources for Alzheimer's Disease.. |
19.12.2023 | 13:30 | GlobeNewswire Inc. | Centralized Marketing Authorizations of Generic Versions of.. |
15.12.2023 | 15:05 | GlobeNewswire Inc. | CHMP Issues Positive Opinion for Biogen’s SKYCLARYS®.. |
14.12.2023 | 12:30 | GlobeNewswire Inc. | ZURZUVAE™ (zuranolone) CIV, a Landmark Oral Treatment for.. |
Forum Biogen
Keine Diskussionen Gefunden.Neuen Thread Erstellen
1BIIB Historisch
Zeitraum † | Handelsbeginn | Hoch | Niedrig | VWAP | Durchsch. Volumen | Änderung | % |
---|---|---|---|---|---|---|---|
1 Woche | 177,65 | 194,00 | 177,65 | 192,22 | 92 | 11,45 | 6,45% |
1 Monat | 191,10 | 194,90 | 177,65 | 191,77 | 47 | -2,00 | -1,05% |
3 Monate | 226,00 | 229,20 | 177,65 | 200,95 | 38 | -36,90 | -16,33% |
6 Monate | 215,60 | 244,60 | 177,65 | 207,18 | 30 | -26,50 | -12,29% |
1 Jahr | 215,60 | 244,60 | 177,65 | 207,18 | 30 | -26,50 | -12,29% |
3 Jahre | 215,60 | 244,60 | 177,65 | 207,18 | 30 | -26,50 | -12,29% |
5 Jahre | 215,60 | 244,60 | 177,65 | 207,18 | 30 | -26,50 | -12,29% |